![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 27, 20647-20651, July 7, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From Amgen, Inc., Thousand Oaks, California 91320-1799
Beta-site amyloid precursor protein cleaving
enzyme (BACE) is a novel transmembrane aspartic protease that possesses
all the known characteristics of the
-secretase involved in
Alzheimer's disease (Vassar, R., Bennett, B. D., Babu-Khan, S.,
Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S.,
Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson,
S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E.,
Burgess, T., Louis, J.-C., Collins, F., Treanor, J., Rogers, G., and
Citron, M. (1999) Science 286, 735-741). We have analyzed
the sequence and expression pattern of a BACE homolog termed BACE2.
BACE and BACE2 are unique among aspartic proteases in that they possess a carboxyl-terminal extension with a predicted transmembrane region and
together they define a new family. Northern analysis reveals that BACE2
mRNA is expressed at low levels in most human peripheral tissues
and at higher levels in colon, kidney, pancreas, placenta, prostate,
stomach, and trachea. Human adult and fetal whole brain and most adult
brain subregions express very low or undetectable levels of BACE2
mRNA. In addition, in situ hybridization of adult rat
brain shows that BACE2 mRNA is expressed at very low levels in most
brain regions. The very low or undetectable levels of BACE2 mRNA in
the brain are not consistent with the expression pattern predicted for
-secretase.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF204944.
To whom correspondence should be addressed: Amgen, Inc., One Amgen
Center Drive, M/S 29-2-B, Thousand Oaks, CA 91320-1799. Tel.:
805-447-1289; Fax: 805-480-1347; E-mail: rvassar@amgen.com.
This article has been cited by other articles:
![]() |
S. Sankaranarayanan, E. A. Price, G. Wu, M.-C. Crouthamel, X.-P. Shi, K. Tugusheva, K. X. Tyler, J. Kahana, J. Ellis, L. Jin, et al. In Vivo {beta}-Secretase 1 Inhibition Leads to Brain A{beta} Lowering and Increased {alpha}-Secretase Processing of Amyloid Precursor Protein without Effect on Neuregulin-1 J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 957 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhong, M. Ewers, S. Teipel, K. Burger, A. Wallin, K. Blennow, P. He, C. McAllister, H. Hampel, and Y. Shen Levels of beta-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive Impairment Arch Gen Psychiatry, June 1, 2007; 64(6): 718 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun, Y. Tong, H. Qing, C.-H. Chen, and W. Song Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome FASEB J, July 1, 2006; 20(9): 1361 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun, G. He, and W. Song BACE2, as a novel APP {theta}-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome FASEB J, July 1, 2006; 20(9): 1369 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dominguez, J. Tournoy, D. Hartmann, T. Huth, K. Cryns, S. Deforce, L. Serneels, I. E. Camacho, E. Marjaux, K. Craessaerts, et al. Phenotypic and Biochemical Analyses of BACE1- and BACE2-deficient Mice J. Biol. Chem., September 2, 2005; 280(35): 30797 - 30806. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun, Y. Wang, H. Qing, M. A. Christensen, Y. Liu, W. Zhou, Y. Tong, C. Xiao, Y. Huang, S. Zhang, et al. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes FASEB J, May 1, 2005; 19(7): 739 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kitazume, K. Nakagawa, R. Oka, Y. Tachida, K. Ogawa, Y. Luo, M. Citron, H. Shitara, C. Taya, H. Yonekawa, et al. In Vivo Cleavage of {alpha}2,6-Sialyltransferase by Alzheimer {beta}-Secretase J. Biol. Chem., March 4, 2005; 280(9): 8589 - 8595. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Basi, N. Frigon, R. Barbour, T. Doan, G. Gordon, L. McConlogue, S. Sinha, and M. Zeller Antagonistic Effects of {beta}-Site Amyloid Precursor Protein-cleaving Enzymes 1 and 2 on {beta}-Amyloid Peptide Production in Cells J. Biol. Chem., August 22, 2003; 278(34): 31512 - 31520. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Huse, D. Byant, Y. Yang, D. S. Pijak, I. D'Souza, J. J. Lah, V. M.-Y. Lee, R. W. Doms, and D. G. Cook Endoproteolysis of beta -Secretase (beta -Site Amyloid Precursor Protein-cleaving Enzyme) within Its Catalytic Domain. A POTENTIAL MECHANISM FOR REGULATION J. Biol. Chem., May 2, 2003; 278(19): 17141 - 17149. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fukumoto, B. S. Cheung, B. T. Hyman, and M. C. Irizarry {beta}-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer Disease Arch Neurol, September 1, 2002; 59(9): 1381 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gruninger-Leitch, D. Schlatter, E. Kung, P. Nelbock, and H. Dobeli Substrate and Inhibitor Profile of BACE (beta -Secretase) and Comparison with Other Mammalian Aspartic Proteases J. Biol. Chem., February 8, 2002; 277(7): 4687 - 4693. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Lovestone and D M McLoughlin Protein aggregates and dementia: is there a common toxicity? J. Neurol. Neurosurg. Psychiatry, February 1, 2002; 72(2): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Irizarry, J. J. Locascio, and B. T. Hyman {beta}-Site APP Cleaving Enzyme mRNA Expression in APP Transgenic Mice : Anatomical Overlap with Transgene Expression and Static Levels with Aging Am. J. Pathol., January 1, 2001; 158(1): 173 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Capell, H. Steiner, M. Willem, H. Kaiser, C. Meyer, J. Walter, S. Lammich, G. Multhaup, and C. Haass Maturation and Pro-peptide Cleavage of beta -Secretase J. Biol. Chem., September 29, 2000; 275(40): 30849 - 30854. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Huse, D. S. Pijak, G. J. Leslie, V. M.-Y. Lee, and R. W. Doms Maturation and Endosomal Targeting of beta -Site Amyloid Precursor Protein-cleaving Enzyme. THE ALZHEIMER'S DISEASE beta -SECRETASE J. Biol. Chem., October 20, 2000; 275(43): 33729 - 33737. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Phylip, W. E. Lees, B. G. Brownsey, D. Bur, B. M. Dunn, J. R. Winther, A. Gustchina, M. Li, T. Copeland, A. Wlodawer, et al. The Potency and Specificity of the Interaction between the IA3 Inhibitor and Its Target Aspartic Proteinase from Saccharomyces cerevisiae J. Biol. Chem., January 12, 2001; 276(3): 2023 - 2030. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Steinhilb, R. S. Turner, and J. R. Gaut The Protease Inhibitor, MG132, Blocks Maturation of the Amyloid Precursor Protein Swedish Mutant Preventing Cleavage by beta -Secretase J. Biol. Chem., February 2, 2001; 276(6): 4476 - 4484. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Marcinkeviciene, Y. Luo, N. R. Graciani, A. P. Combs, and R. A. Copeland Mechanism of Inhibition of beta -Site Amyloid Precursor Protein-cleaving Enzyme (BACE) by a Statine-based Peptide J. Biol. Chem., June 22, 2001; 276(26): 23790 - 23794. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yan, J. B. Munzner, M. E. Shuck, and M. J. Bienkowski BACE2 Functions as an Alternative alpha -Secretase in Cells J. Biol. Chem., August 31, 2001; 276(36): 34019 - 34027. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |